FDA confirms Johnson & Johnson vaccine prevented all deaths and hospitalizations in trial

The United States could be days away from getting a third COVID-19 vaccine.
A Food and Drug Administration review has confirmed that Johnson & Johnson's COVID-19 vaccine, which only requires a single shot, is safe and effective, meaning it could be authorized for emergency approval "as soon as this weekend," The Washington Post reports.
The FDA review showed the vaccine was 66 percent effective at preventing moderate to severe COVID-19 in a large clinical trial, though it was 85 percent effective at preventing severe illness. As Johnson & Johnson previously announced, the vaccine also "demonstrated complete protection against COVID-related hospitalization and death, 28 days post-vaccination." That, University of Rochester School of Medicine and Dentistry's Nancy M. Bennett told the Post, is "really what's important."
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
The Johnson & Johnson vaccine comes with the key benefit of only requiring one dose, as opposed to two doses for both the Pfizer and Moderna vaccines that were previously authorized for emergency approval in the United States. Plus, the Johnson & Johnson vaccine can also be stored for three months in a refrigerator, rather than having to be kept frozen, The Associated Press notes.
A committee is set to meet Friday to consider whether the FDA should authorize the Johnson & Johnson vaccine for emergency approval. The company says that should the FDA do so, it expects to begin shipping the vaccine immediately and "deliver enough single-doses by the end of March to enable the vaccination of more than 20 million Americans."
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Brendan worked as a culture writer at The Week from 2018 to 2023, covering the entertainment industry, including film reviews, television recaps, awards season, the box office, major movie franchises and Hollywood gossip. He has written about film and television for outlets including Bloody Disgusting, Showbiz Cheat Sheet, Heavy and The Celebrity Cafe.
-
Today's political cartoons - March 1, 2025
Cartoons Saturday's cartoons - low morale, mental health tips, and more
By The Week US Published
-
5 hilariously productive cartoons about 5 things Elon Musk did last week
Cartoons Artists take on proactivity, a busy week, and more
By The Week US Published
-
Will Amazon destroy James Bond?
Talking Point Broccoli family yields control of franchise to tech giant, sparking fears of corporate 'Americanisation' of beloved British icon
By The Week UK Published
-
Texas outbreak brings 1st US measles death since 2015
Speed read The outbreak is concentrated in a 'close-knit, undervaccinated' Mennonite community in rural Gaines County
By Rafi Schwartz, The Week US Published
-
Mystery illness spreading in Congo rapidly kills dozens
Speed Read The World Health Organization said 53 people have died in an outbreak that originated in a village where three children ate a bat carcass
By Peter Weber, The Week US Published
-
Ozempic can curb alcohol cravings, study finds
Speed read Weight loss drugs like Ozempic and Wegovy may also be helpful in limiting alcohol consumption
By Peter Weber, The Week US Published
-
New form of H5N1 bird flu found in US dairy cows
Speed Read This new form of bird flu is different from the version that spread through herds in the last year
By Peter Weber, The Week US Published
-
Microplastics accumulating in human brains, study finds
Speed Read The amount of tiny plastic particles found in human brains increased dramatically from 2016 to 2024
By Peter Weber, The Week US Published
-
FDA approves painkiller said to thwart addiction
Speed Read Suzetrigine, being sold as Journavx, is the first new pharmaceutical pain treatment approved by the FDA in 20 years
By Rafi Schwartz, The Week US Published
-
Study finds possible alternative abortion pill
Speed Read An emergency contraception (morning-after) pill called Ella could be an alternative to mifepristone for abortions
By Peter Weber, The Week US Published
-
California declares bird flu emergency
Speed Read The emergency came hours after the nation's first person with severe bird flu infection was hospitalized
By Rafi Schwartz, The Week US Published